Physician profile
Robert M Cain
NPI 1205051042
$605.11
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $546 · 2020: $35.28 · 2024: $23.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $23.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $23.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $165.43 | 2019 | |
| Arbor Pharmaceuticals, INC. | $70.73 | 2019 | |
| Scilex Pharmaceuticals INC. | $64.43 | 2019 | |
| Ironshore Pharmaceuticals INC. | $61.21 | 2019-2020 | |
| Shire North American Group INC | $57.53 | 2019 | |
| Jazz Pharmaceuticals INC. | $51.59 | 2019 | |
| Abiomed | $23.96 | 2024 | Impella |
| Ucb, INC. | $21.58 | 2019 | |
| Neos Therapeutics, LP | $20.41 | 2019 | |
| Aytu Biopharma, INC. | $20.26 | 2019 | |
| Promius Pharma LLC | $19.23 | 2019 | |
| Avanir Pharmaceuticals, INC. | $14.96 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Cain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.